Nuvation Bio (NYSE: NUVB) is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco.
Location: United States, New York
Employees: 51-200
Total raised: $275M
Founded date: 2018
Investors 7
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
| - | Omega Fund... | omegafunds... |
| - | Ally Bridg... | ally-bridg... |
| - | Biobrit | biobrit.co... |
| - | EcoR1 Capi... | ecor1cap.c... |
| - | Perceptive... | perceptive... |
| - | Altitude L... | altitudels... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.10.2019 | Series A | $275M | Omega Fund... |
Mentions in press and media 22
| Date | Title | Description | Source |
| 20.01.2022 | Nuvation Bio Announces FDA Clearance of Investigational New ... | NEW YORK, Jan. 20, 2022 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company ... | marketscre... |
| 15.12.2021 | Nuvation Bio Receives FDA Fast Track Designation for NUV-422... | NEW YORK, Dec. 15, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company ... | marketscre... |
| 13.12.2021 | Nuvation Bio Announces FDA Clearance of Investigational New ... | NEW YORK, Dec. 13, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company ... | marketscre... |
| 08.12.2021 | Nuvation Bio Announces FDA Clearance of Investigational New ... | NEW YORK, Dec. 8, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company t... | marketscre... |
| 11.11.2021 | Nuvation Bio Reports Third Quarter 2021 Financial Results an... | NEW YORK, Nov. 10, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company ... | marketscre... |
| 10.11.2021 | Nuvation Bio Reports Third Quarter 2021 Financial Results an... | NEW YORK, Nov. 10, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company ... | salamancap... |
| 12.08.2021 | Nuvation Bio Reports Second Quarter 2021 Financial Results a... | NEW YORK, Aug. 12, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company ... | salamancap... |
| 17.05.2021 | Nuvation Bio Reports First Quarter 2021 Financial Results an... | NEW YORK, May 17, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company t... | salamancap... |
| 11.03.2021 | Nuvation Bio Reports Full Year 2020 Financial Results and Pr... | NEW YORK, March 11, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company... | salamancap... |
| 10.03.2021 | NUVATION BIO INC. Panacea Acquisition : Nuvation Bio Closes... | Combined company renamed Nuvation Bio Inc., will be listed on the New York Stock Exchange under tick... | marketscre... |
Show more